[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100625767":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":33,"responsibleParty":65,"collaborators":20,"id":67,"slug":20,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":20,"eligibilityCriteria":72,"healthyVolunteers":68,"sex":73,"minAge":74,"maxAge":20,"enrollmentInfo":75,"targetDuration":20,"studyType":78,"phases":79,"briefSummary":81,"conditions":82,"keywords":87,"overallStatus":36,"whyStopped":20,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"Virginia Commonwealth University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Virtual Reality Group","EXPERIMENTAL","Individuals in this arm will receive access to the virtual reality in cardiovascular health education and gaming intervention",[13],"Behavioral: Cardiovascular Health Education and Gaming through Virtual Reality",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"BEHAVIORAL","Cardiovascular Health Education and Gaming through Virtual Reality","Prior to engaging the intervention, participants will complete a baseline survey. The virtual reality intervention will be delivered at one infusion treatment. Participants will complete all education modules and affiliated games. The education focuses on potentially cardiotoxic treatments (e.g., anthracyclines), ways to identify cancer treatment related cardiovascular dysfunction, and heart healthy behaviors that survivors can initiate during survivorship. Following the intervention participants will complete a survey similar to the baseline survey. One-month following the intervention participants will complete one final survey.",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Arnethea Sutton, Ph.D","PRINCIPAL_INVESTIGATOR",[26,30],{"name":23,"role":27,"phone":28,"phoneExt":20,"email":29},"CONTACT","8048277363","careslab@vcu.edu",{"name":31,"role":27,"phone":28,"phoneExt":20,"email":32},"Victoria Williams","williamsv4@vcu.edu",[34,50,57],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Adult Outpatient Pavilion","RECRUITING","Richmond","Virginia","23220","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-77.46026,37.55376,{"lat":46,"lon":45},[49],{"name":31,"role":27,"phone":28,"phoneExt":20,"email":32},{"facility":51,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":52,"geoPoint":54,"contacts":55},"Cellular Immunotherapies and Transplant Department",{"type":43,"coordinates":53},[45,46],{"lat":46,"lon":45},[56],{"name":31,"role":27,"phone":28,"phoneExt":20,"email":32},{"facility":58,"status":36,"city":37,"state":38,"zip":59,"country":40,"countryCode":41,"cosmosGeoPoint":60,"geoPoint":62,"contacts":63},"VCU Health at Stony Point","23223",{"type":43,"coordinates":61},[45,46],{"lat":46,"lon":45},[64],{"name":31,"role":27,"phone":28,"phoneExt":20,"email":32},{"type":66,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100625767",false,"NCT07426913","Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab","Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab - Phase 2","Inclusion Criteria:\n\n* 18 years of age or older\n* Able to speak and read in English\n* Actively receiving Trastuzumab or an anthracycline-based treatment\n* Currently receiving immunotherapy. This includes pembrolizumab and atezolizumab.\n* Diagnosed with stages 0-III Breast Cancer\n\nExclusion Criteria:\n\n\\- History of prior Breast Cancer diagnosis (i.e., not their first breast cancer diagnosis)","FEMALE","18 Years",{"count":76,"type":77},30,"ESTIMATED","INTERVENTIONAL",[80],"NA","The main goal of this study is to test a virtual reality (VR) program, Survivors' Virtual Reality Survivorship Experience (SurviVRSE), designed to help Breast Cancer survivors (n=30) learn about heart health. The aims are to test the usability, feasibility, and acceptability o the intervention. Additionally, follow-up assessments will examine changes in women's cancer therapy related cardiac dysfunction knowledge and heart healthy behaviors (e.g., physical activity).",[83,84,85,86],"Breast Cancer","Anthracycline Related Cardiotoxicity in Breast Cancer","Virtual Reality","Trastuzumab",[88,89,90,91,92,5],"virtual reality","breast cancer","antracyclines","trastuzumab","VCU","2026-07-01",{"date":95,"type":96},"2026-07-02","ACTUAL",{"date":98,"type":96},"2026-05-20",{"date":100,"type":77},"2027-02-28",{"name":5,"class":6},3]